Several GLP-1 receptor agonists are currently licensed for use in the UK, including semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Bydureon BCise), and lixisenatide (Lyxumia)
Tirzepatide offers a non-surgical alternative that may be appropriate for many individuals looking to manage their weight effectively
Side effects vary from person to person, but many patients experience similar issues with both medications
With continued use, skin appears clearer, smoother, and more radiant, making it suitable for everyday cleansing
These inflammatory cascades damage neural networks involved in memory, emotional regulation, and decision-making, compounding the cognitive and affective symptoms that undermine recovery efforts